Health-related quality of life in hepatitis C patients who achieve sustained virological response to direct-acting antivirals: a comparison with the general population
- 21 January 2019
- journal article
- research article
- Published by Springer Nature in Quality of Life Research
- Vol. 28 (6) , 1477-1484
Abstract
Purpose To compare health-related quality of life (HRQoL) between hepatitis C patients who achieve sustained virological response (SVR) to direct-acting antivirals and a sex- and age-paired sample of the general population. Methods HRQoL was evaluated in patients recruited in Navarre, Spain, from May 2016 to April 2017 at baseline and after SVR, using the EQ-5D-5L questionnaire. Both results were compared to those of general population of the same sex and age obtained from the 2011/12 National Health Survey in Spain. Observed/expected (O/E) ratios for health dimensions and differences between O-E in EQ-5D utility and visual analogical scale (VAS) scores were calculated. Results 206 patients were studied. Before treatment, patients had more problems than the general population in every domain of EQ-5D-5L, except in self-care dimension (O/E = 1.1). After SVR, patients continued having more limitation, especially for usual activities (O/E = 3.1), anxiety/depression (O/E = 2.8) and EQ-5D utility (− 0.086, p < 0.001); however, differences in VAS score between patients and general population disappeared (74.8 vs 76.5, p = 0.210). F0–F1 patients with SVR had minor differences with the general population in EQ-5D-5L dimensions, utility and VAS score. Although cirrhotic patients also reduced that difference, they still had worse HRQoL, especially in usual activities, self-care, EQ-5D utility (− 0.152, p < 0.001) and VAS score (− 8.5, p = 0.005). Conclusions HRQoL of chronic hepatitis C patients remains lower than that of the general population despite viral clearance, with primary problems in usual activities and anxiety/depression. Knowledge of these on-going problems despite cure serves to guide healthcare interventions and patient’s follow-up.Keywords
Funding Information
- Spanish Ministry of Health and Carlos III Health Institute (EIPT-VHC)
- Carlos III Institute of Health with the European Regional Development Fund (CM17/00095, INT17/00066)
This publication has 34 references indexed in Scilit:
- Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country studyQuality of Life Research, 2012
- PGI15 The Cost and Quality of Life of Hepatitis C in the NetherlandsValue in Health, 2011
- Patient‐reported outcome measures in the NHS: new methods for analysing and reporting EQ‐5D dataHealth Economics, 2010
- Role of “health-related quality of life” measurements in the design of drug clinical trialsFarmacia Hospitalaria, 2010
- Health-related quality of life in patients with different stages of liver disease induced by hepatitis CScandinavian Journal of Gastroenterology, 2009
- The effects of HCV infection and management on health-related quality of lifeHepatology, 2007
- Quality of life and cognitive function in hepatitis C at different stages of liver diseaseJournal of Hepatology, 2003
- Measuring the health burden of chronic disease and injury using health adjusted life expectancy and the Health Utilities IndexJournal of Epidemiology and Community Health, 2002
- Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosisHepatology, 1998
- An Algorithm for the Grading of Activity in Chronic Hepatitis CHepatology, 1996